FindTrial
Sign In

Assessment of the effects of topical post-operative administration of nepafenac 0.1% eye drops on occurrence of macular edema in patient undergoing cataract surgery

Assessment of the effects of topical post operative administration of nepafenac 0.1% eye drops on occurrence of macular edema in patients undergoing manual small incision cataract surgery-a triple blinded randomisation control trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050910
Enrollment
72
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H358- Other specified retinal disorders

Interventions

Intervention1: Nepafenac 0.1% Eye drops: post operative small incision cataract surgery patient included in this study treated additionally to standard treatment with nepafenac 0.1% eyedrops from post

Sponsors

A Mohamed shakil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with senile cataract more than 50 years of age.

Exclusion criteria

Exclusion criteria: Patient with anterior segment pathology (corneal opacities, pseudo exfoliation syndrome and dense cataract interfering with OCT imaging); patient with traumatic or complicated cataract history of topical or systemic NSAID use prior to surgery, allergy or hypersensitivity to NSAIDs, previous ocular surgery, amblyopia, retinal abnormalities, connective tissue disease, diabetes mellitus, steroid, or immunosuppressive treatment, and any intraoperative or postoperative complication.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of topical postoperative administration of nepafenac 0.1% eye drops on occurrence of macular edema in patient undergoing uncomplicated cataract surgeryTimepoint: 6 weeks—

Secondary

MeasureTime frame
To emphazize the importance of obtaining optimum visual acuity by preventing cystoid macular edemaTimepoint: 6 weeks—

Countries

India

Contacts

Public ContactP Nallamuthu

Sri Manakula Vinayagar Medical college and Hospital

drpnallamuthu@gmail.com9843890074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026